Table 7.
Albumin/creatinine > 30 during follow up | ||||
---|---|---|---|---|
Age |
Amalgam events / visits |
Composite events / visits |
Odds Ratio (amal/comp) |
p-value |
9 | 3 / 32 | 5 / 37 | 0.7 | 0.72 |
10 | 4 / 95 | 13 / 107 | 0.3 | 0.52 |
11 | 12 / 182 | 15 / 178 | 0.8 | 0.69 |
12 | 21 / 231 | 26 / 230 | 0.8 | 0.67 |
13 | 33 / 235 | 37 / 229 | 0.8 | 0.70 |
14 | 22 / 206 | 26 / 224 | 0.9 | 0.78 |
15 | 18 / 197 | 33 / 211 | 0.5 | 0.52 |
16 | 17 / 158 | 17 / 132 | 0.8 | 0.72 |
17 | 14 / 103 | 8 / 83 | 1.5 | 0.66 |
18 | 3 / 30 | 3 / 29 | 1.0 | 0.83 |
Wald tests were used to test for a difference in the log odds of albumin/creatinine > 30 (odds ratio different from 1) at each age during follow-up.